Home > Analytics > ALEMBIC PHARMACEUTICALS

ALEMBIC PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

BOM : 533573     NSE : APLLTD    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Apr 15,2024
Price(EOD): ₹ 968.60
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 19,042.68 Cr
Value of ₹ 1 Lac invested in ALEMBIC PHARMACEUTICALS
on Apr 15,2019 (price: ₹ 532.75)

₹ 1 L

₹ 1.82 L

1W : 3% 1M : -8.2% 1Y : 93.9%
COMMUNITY POLL
for ALEMBIC PHARMACEUTICALS
Please provide your vote to see the results
ALEMBIC PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
ALEMBIC PHARMACEUTICALS 3% -8.2% 93.9%
SUN PHARMACEUTICAL INDUSTRIES 3% 2.3% 68.2%
CIPLA 2.5% 0.4% 71.7%
DR REDDYS LABORATORIES -0.2% -4.9% 40.3%
ZYDUS LIFESCIENCES 5% 10.4% 109.1%
DIVIS LABORATORIES -1.6% -7% 23.8%
MANKIND PHARMA NA NA NA
TORRENT PHARMACEUTICALS 2.9% -2.2% 69%
LUPIN 2.8% 0% 147.8%

FUNDAMENTAL ANALYSIS OF ALEMBIC PHARMACEUTICALS

 
Fundamentals Score
[ Q(TTM): Dec2023, Y: Mar2023
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 APLLTD is one of the top 35% companies with good fundamentals ! Discover More →

VALUATION OF ALEMBIC PHARMACEUTICALS

 
Valuation Score
[As on : Apr 15,2024 ]

Ratio Consolidated
P/E
P/B
P/S
31.77
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 599.25 Cr
[Latest Qtr - Dec2023 - Consolidated Results ]

4.36
P/B Calculated based on Book Value of Rs 4,370.47 Cr
[Latest Year - Mar2023 - Consolidated Results ]

3.11
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 6,118.10 Cr
[Latest Qtr - Dec2023 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 14% undervalued companies ! Discover More →

FAIR VALUE OF ALEMBIC PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
82%
2%
0%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF ALEMBIC PHARMACEUTICALS



ALEMBIC PHARMACEUTICALS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF ALEMBIC PHARMACEUTICALS

Year Debt/Equity ratio
Standalone Consolidated
2023
2022
2021
Avg_3yrs
0.14
0.12
0.1
0.12
0.15
0.12
0.1
0.12
[Last Annual Data : Mar2023]
Financial Ratios →

PLEDGED PROMOTER SHARES OF ALEMBIC PHARMACEUTICALS

Pledged Promoter Shares
0 %
As on : Dec2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF ALEMBIC PHARMACEUTICALS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
2.23%
27.91%
36.62%
31.68%
8.05%
7.08%
9.84%
33.19%
QtrlyTrend
8
Latest Qtr: Dec2023
Quarterly Result Analysis →


ALEMBIC PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
S&P BSE 250 SMALLCAP -1% 3.9% 61.9%
S&P BSE 500 -1.1% 0.9% 37.6%
S&P BSE ALLCAP -1.2% 1% 39.4%
S&P BSE 400 MIDSMALLCAP -1.3% 2.4% 58.9%
S&P BSE MIDSMALLCAP -1.6% 2.3% 63.6%
NSE Indices1W1M1Y
NIFTY MID SMALL400 -1% 2.8% 61.6%
NIFTY SMALLCAP250 -1.1% 4% 67.7%
NIFTY500 MULTICAP 50:25:25 -1.1% 1.7% 46.9%
NIFTY 500 -1.1% 0.9% 38.5%

You may also like the below Video Courses


FAQ about ALEMBIC PHARMACEUTICALS


Is ALEMBIC PHARMACEUTICALS good for long term investment?

As on Apr 15,2024, the Fundamentals of ALEMBIC PHARMACEUTICALS look Strong and hence it may be good for long term investment! See Financial Performance of ALEMBIC PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is ALEMBIC PHARMACEUTICALS UnderValued or OverValued?

As on Apr 15,2024, ALEMBIC PHARMACEUTICALS is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of ALEMBIC PHARMACEUTICALS ?

As on Apr 15,2024, the Intrinsic Value of ALEMBIC PHARMACEUTICALS is Rs. 951.48 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 533.65
Fair Value [Median EV / Sales Model] : Rs. 951.48
Fair Value [Median Price / Sales Model] : Rs. 965.09
Estimated Median Fair Value of ALEMBIC PHARMACEUTICALS : Rs. 951.48

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is ALEMBIC PHARMACEUTICALS trading at a Premium or Discount?

As on Apr 15,2024, ALEMBIC PHARMACEUTICALS is trading at a Premium of 2% based on the estimates of Median Intrinsic Value!